Evotec SE EVO
NASDAQ EVO
$1.93 -0.03 (-1.52%)
As of: Aug 21, 2026 · 3:59 PM EDT

Evotec SE (EVO) Net Margin Growth (3y) (2022 - 2025)

Evotec SE (EVO) Net Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 948.00
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -491.00
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 83.00
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -94.00
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -990.00
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -604.00
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 1,312.00
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Evotec SE 687.23 Mn 686.75 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -640,218.00
Sep 30, 2025 -5,332.00
Dec 31, 2024 -13.85 Mn
Sep 30, 2024 -11,337.00
Dec 31, 2023 -1.62 Mn
Dec 31, 2022 -3.44 Mn